Innovita Biological Technology Co., Ltd. (SHA:688253)

Market Cap	7.54B +79.7%
Revenue (ttm)	286.33M -39.9%
Net Income	50.52M -69.5%
EPS	0.37 -69.3%
Shares Out	134.87M
PE Ratio	150.45
Forward PE	60.11
Dividend	0.45 (0.81%)
Ex-Dividend Date	Jun 16, 2026

Volume	1,523,127
Open	55.72
Previous Close	55.90
Day's Range	54.51 - 57.60
52-Week Range	29.99 - 73.58
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 571
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688253

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 144.47 million, a decrease of -41.48%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 2, 2026

Data Sources Report a data error